ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

233
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
29 Apr 2018 20:57

Japan Sector Weights : 3 Month Incremental Change - Domestic Sectors ▲ Global Sectors ▼

TOPIX SECTOR CLASSIFICATIONS ARE 50 YEARS OLD - The TOPIX 17 and TOPIX 33 Sectors that most analysts use to monitor sectoral performance were first...

Logo
160 Views
Share
bullishShire PLC
27 Apr 2018 09:18

Maintaining Our FVE for Shire and Takeda During Extended Offer Period

We’re not making any changes to our fair value estimates for Shire PLC (SHP LN) (GBP 48.90 per share/$205 per ADR) or Takeda Pharmaceutical Co Ltd...

Logo
131 Views
Share
25 Apr 2018 23:54

No Deal Is a Big Deal for Takeda

Takeda Pharmaceutical Co Ltd (4502 JP)'s revised April 24, 2018 proposal of £49 / share (~$206 / ADS), values Shire PLC (SHP LN) at ~$64b, its...

23 Apr 2018 13:49

The Week That Was in NorthAsia@Smartkarma: Itochu/FamilyMart, Samsung, Suruga, & Renesas

Below is the full list of Japan/Korea related reports published last week on Smartkarma.Itochu Tender For FamilyMartTravis Lundy explained the...

Logo
193 Views
Share
22 Apr 2018 20:49

Takeda Sweetens Offer for Shire: Deal – You Win! No-Deal – You Win Too!

Takeda Pharmaceutical Co Ltd (4502 JP)'s revised April 20, 2018 proposal of £47 / share (~$197.4 / ADS), valuing Shire PLC (SHP LN) at ~$60b, is...

x